Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FENXR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,795
Award facts
- Contract value 100% obligated
- $5,795.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $5,795.49 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 15, 2025, with an ultimate completion date of December 16, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency—specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative—which was awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036.
DMS Pharmaceutical Group serves as a critical supplier within the Department of Defense's pharmaceutical supply chain, distributing a comprehensive range of products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals to military healthcare facilities worldwide. The vendor's IDC positions it as one of multiple regional prime vendor contractors under the broader $30.3 billion PPV-G GEN V acquisition strategy, which enables the Defense Logistics Agency to issue delivery orders for recurring medical supply needs across the military health system. The company's established performance on numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of federal military medical operations.
Quick answers
Who was awarded contract SPE2DU26FENXR?
SPE2DU26FENXR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DU26FENXR worth?
The government has obligated $5,795 on SPE2DU26FENXR.
Is contract SPE2DU26FENXR an order under another contract?
Yes. SPE2DU26FENXR is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENXR competed?
The extent of competition for SPE2DU26FENXR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award